Get a jump start on the US trading day with Matt Miller and Dani Burger on "Bloomberg Open Interest." The weight-loss drug war takes a sharp turn. Novo Nordisk rebounds as Hims & Hers pulls a copycat version of its Wegovy weight-loss drug. Plus, Alphabet borrows fifteen billion dollars—-as the AI boom accelerates. Meanwhile, China urges banks to cut Treasury exposure, Goldman warns traders to buckle up, and Apollo shatters lending records. Plus—an American activist takes on Swiss icon Swatch, and Edgewell’s President and CEO breaks down the quarter. (Source: Bloomberg)